Company intelligence
Sus Clinicals, Inc.
Enabling our healthcare client partners to accelerate breakthrough cancer solutions.
About Sus Clinicals, Inc.
Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies.
Verified activity
Signals from Sus Clinicals, Inc.
3 published signals
Research & Knowledge
Sus Clinicals, Inc. published a manuscript comparing other AI tools to Oncoscopes living library.
Reported by Jessicca R.
Presence & Recognition
Sus Clinicals, Inc. will be presenting at CIRSE next week.
Reported by Sus Clinicals, Inc.
Presence & Recognition
Sus Clinicals, Inc. has been selected as a 2026–2027 NCI SBIR Showcase Company
Reported by Sus Clinicals, Inc.